283 related articles for article (PubMed ID: 31124282)
1. Chemical profiling of the synthetic cannabinoid MDMB-CHMICA: Identification, assessment, and stability study of synthesis-related impurities in seized and synthesized samples.
Münster-Müller S; Hansen S; Opatz T; Zimmermann R; Pütz M
Drug Test Anal; 2019 Aug; 11(8):1192-1206. PubMed ID: 31124282
[TBL] [Abstract][Full Text] [Related]
2. A Novel Impurity-Profiling Workflow with the Combination of Flash-Chromatography, UHPLC-MS, and Multivariate Data Analysis for Highly Pure Drugs: A Study on the Synthetic Cannabinoid MDMB-CHMICA.
Münster-Müller S; Zimmermann R; Pütz M
Anal Chem; 2018 Sep; 90(17):10559-10567. PubMed ID: 30079731
[TBL] [Abstract][Full Text] [Related]
3. Analytically Confirmed Intoxications Involving MDMB-CHMICA from the STRIDA Project.
Bäckberg M; Tworek L; Beck O; Helander A
J Med Toxicol; 2017 Mar; 13(1):52-60. PubMed ID: 27638057
[TBL] [Abstract][Full Text] [Related]
4. Combination of stable isotope ratio data and chromatographic impurity signatures as a comprehensive concept for the profiling of highly prevalent synthetic cannabinoids and their precursors.
Münster-Müller S; Scheid N; Zimmermann R; Pütz M
Anal Chim Acta; 2020 Apr; 1108():129-141. PubMed ID: 32222234
[TBL] [Abstract][Full Text] [Related]
5. Phase I metabolism of the highly potent synthetic cannabinoid MDMB-CHMICA and detection in human urine samples.
Franz F; Angerer V; Moosmann B; Auwärter V
Drug Test Anal; 2017 May; 9(5):744-753. PubMed ID: 27504870
[TBL] [Abstract][Full Text] [Related]
6. MDMB-CHMICA: Availability, Patterns of Use, and Toxicity Associated With This Novel Psychoactive Substance.
Haden M; Archer JR; Dargan PI; Wood DM
Subst Use Misuse; 2017 Jan; 52(2):223-232. PubMed ID: 27759479
[TBL] [Abstract][Full Text] [Related]
7. 4F-MDMB-BINACA: A New Synthetic Cannabinoid Widely Implicated in Forensic Casework.
Krotulski AJ; Mohr ALA; Kacinko SL; Fogarty MF; Shuda SA; Diamond FX; Kinney WA; Menendez MJ; Logan BK
J Forensic Sci; 2019 Sep; 64(5):1451-1461. PubMed ID: 31260580
[TBL] [Abstract][Full Text] [Related]
8. Profiling of synthesis-related impurities of the synthetic cannabinoid Cumyl-5F-PINACA in seized samples of e-liquids via multivariate analysis of UHPLC-MS
Münster-Müller S; Matzenbach I; Knepper T; Zimmermann R; Pütz M
Drug Test Anal; 2020 Jan; 12(1):119-126. PubMed ID: 31307120
[TBL] [Abstract][Full Text] [Related]
9. Schedules of Controlled Substances: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA) into Schedule I. Temporary Scheduling Order.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2017 Apr; 82(67):17119-24. PubMed ID: 28425681
[TBL] [Abstract][Full Text] [Related]
10. Methyl (S)-2-(1-7 (5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (5F-MDMB-PICA) intoxication in a child with identification of two new metabolites (ultra-high-performance liquid chromatography-tandem mass spectrometry).
Szpot P; Nowak K; Wachełko O; Tusiewicz K; Chłopaś-Konowałek A; Zawadzki M
Forensic Toxicol; 2023 Jan; 41(1):47-58. PubMed ID: 36652054
[TBL] [Abstract][Full Text] [Related]
11. In vitro Phase I metabolism of indazole carboxamide synthetic cannabinoid MDMB-CHMINACA via human liver microsome incubation and high-resolution mass spectrometry.
Presley BC; Logan BK; Jansen-Varnum SA
Drug Test Anal; 2019 Aug; 11(8):1264-1276. PubMed ID: 31108568
[TBL] [Abstract][Full Text] [Related]
12. Analysis and clinical findings of cases positive for the novel synthetic cannabinoid receptor agonist MDMB-CHMICA.
Seywright A; Torrance HJ; Wylie FM; McKeown DA; Lowe DJ; Stevenson R
Clin Toxicol (Phila); 2016 Sep; 54(8):632-7. PubMed ID: 27213960
[TBL] [Abstract][Full Text] [Related]
13. Development and Validation of a Rapid Method for Identification of New Synthetic Cannabinoids in Hair Based on High-Performance Liquid Chromatography-Ion Trap Mass Spectrometry Using a Simplified User Interface.
Musile G; Palacio C; Murari M; Appolonova S; Tagliaro F
J Anal Toxicol; 2023 Feb; 47(1):72-80. PubMed ID: 35536611
[TBL] [Abstract][Full Text] [Related]
14. Clinical toxicity following analytically confirmed use of the synthetic cannabinoid receptor agonist MDMB-CHMICA. A report from the Identification Of Novel psychoActive substances (IONA) study.
Hill SL; Najafi J; Dunn M; Acheampong P; Kamour A; Grundlingh J; Blain PG; Thomas SH
Clin Toxicol (Phila); 2016 Sep; 54(8):638-43. PubMed ID: 27251903
[TBL] [Abstract][Full Text] [Related]
15. The impact of the Psychoactive Substances Act 2016 on the online availability of MDMB-CHMICA.
Haden M; Wood DM; Dargan PI
QJM; 2017 Oct; 110(10):619-622. PubMed ID: 28339898
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of an indazole-3-carboxamide class synthetic cannabinoid: 2-[1-(cyclohexylmethyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoic acid (DMBA-CHMINACA).
Lee JH; Jung A; Park HN; Lee C; Mandava S; Lim SJ; Lim BB; Park SK; Lee J; Kang H
Forensic Sci Int; 2018 Oct; 291():167-174. PubMed ID: 30216842
[TBL] [Abstract][Full Text] [Related]
17. Schedules of Controlled Substances: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB- CHMICA and MDMB-FUBINACA) Into Schedule I. Notice of Intent.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2016 Dec; 81(245):93595-9. PubMed ID: 28068047
[TBL] [Abstract][Full Text] [Related]
18. Post-mortem distribution of the synthetic cannabinoid MDMB-CHMICA and its metabolites in a case of combined drug intoxication.
Gaunitz F; Lehmann S; Thomas A; Thevis M; Rothschild MA; Mercer-Chalmers-Bender K
Int J Legal Med; 2018 Nov; 132(6):1645-1657. PubMed ID: 30219927
[TBL] [Abstract][Full Text] [Related]
19. Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA.
Hermanns-Clausen M; Müller D; Kithinji J; Angerer V; Franz F; Eyer F; Neurath H; Liebetrau G; Auwärter V
Clin Toxicol (Phila); 2018 Jun; 56(6):404-411. PubMed ID: 29072524
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Synthetic Cannabinoid Metabolites in Human Blood in the Absence of Parent Compounds: A Stability Assessment.
Krotulski AJ; Bishop-Freeman SC; Mohr ALA; Logan BK
J Anal Toxicol; 2021 Feb; 45(1):60-68. PubMed ID: 32435808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
